A detailed history of Sg Americas Securities, LLC transactions in Veru Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 66,128 shares of VERU stock, worth $46,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,128
Previous 23,131 185.88%
Holding current value
$46,950
Previous $19,000 168.42%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$0.77 - $1.04 $33,107 - $44,716
42,997 Added 185.88%
66,128 $51,000
Q2 2024

Jul 12, 2024

BUY
$0.76 - $1.79 $1,206 - $2,840
1,587 Added 7.37%
23,131 $19,000
Q1 2024

May 06, 2024

BUY
$0.37 - $0.72 $1,819 - $3,540
4,917 Added 29.57%
21,544 $15,000
Q4 2023

Jan 12, 2024

BUY
$0.67 - $1.17 $11,140 - $19,453
16,627 New
16,627 $12,000
Q2 2023

Jul 10, 2023

SELL
$0.98 - $1.49 $73,695 - $112,046
-75,199 Reduced 48.4%
80,180 $95,000
Q1 2023

Apr 28, 2023

BUY
$1.16 - $6.41 $135,121 - $746,662
116,484 Added 299.48%
155,379 $180,000
Q4 2022

Feb 02, 2023

SELL
$4.78 - $15.01 $225,066 - $706,745
-47,085 Reduced 54.76%
38,895 $205,000
Q3 2022

Oct 31, 2022

BUY
$10.22 - $23.7 $762,074 - $1.77 Million
74,567 Added 653.35%
85,980 $990,000
Q2 2022

Jul 29, 2022

BUY
$4.35 - $15.85 $49,646 - $180,896
11,413 New
11,413 $129,000
Q1 2022

Apr 29, 2022

SELL
$4.55 - $6.41 $54,463 - $76,727
-11,970 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$5.89 - $9.73 $98,575 - $162,841
-16,736 Reduced 58.3%
11,970 $71,000
Q3 2021

Nov 01, 2021

BUY
$6.78 - $9.89 $194,626 - $283,902
28,706 New
28,706 $245,000
Q3 2020

Nov 09, 2020

SELL
$2.58 - $3.36 $69,257 - $90,195
-26,844 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$3.01 - $4.02 $80,800 - $107,912
26,844 New
26,844 $90,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $56.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.